Chemoinformaics analysis of Isorhamnetin 3-sophoroside
| Molecular Weight | 640.547 | nRot | 8 |
| Heavy Atom Molecular Weight | 608.291 | nRig | 30 |
| Exact Molecular Weight | 640.164 | nRing | 5 |
| Solubility: LogS | -3.473 | nHRing | 3 |
| Solubility: LogP | -1.039 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 2 |
| nHetero | 17 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 17 | No. of Arom Bond | 17 |
| nHA | 17 | APOL | 81.7314 |
| nHD | 10 | BPOL | 43.3866 |
| QED | 0.123 |
| Synth | 4.754 |
| Natural Product Likeliness | 1.852 |
| NR-PPAR-gamma | 0.872 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.984 |
| HIA | 0.964 |
| CACO-2 | -6.365 |
| MDCK | 0.0000856 |
| BBB | 0.301 |
| PPB | 0.778456 |
| VDSS | 0.675 |
| FU | 0.246504 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.031 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.183 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.164 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.004 |
| CL | 1.291 |
| T12 | 0.566 |
| hERG | 0.017 |
| Ames | 0.732 |
| ROA | 0.045 |
| SkinSen | 0.017 |
| Carcinogencity | 0.044 |
| EI | 0.005 |
| Respiratory | 0.01 |
| NR-Aromatase | 0.893 |
| Antiviral | Yes |
| Prediction | 0.79227 |